SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ: BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that BSD’s exclusive Taiwan distributor, Linden Bioscience Co., Ltd., (Linden) has obtained Taiwan Food and Drug Administration (TFDA) marketing approval for the BSD-2000 Hyperthermia System (BSD-2000). Linden is a leading distributor of sophisticated medical devices in Taiwan. Linden has committed to an initial purchase of four BSD-2000 Hyperthermia Systems for market introduction. BSD will ship the systems in the current fiscal year ending August 31, 2014.
Help employers find you! Check out all the jobs and post your resume.
